TNNC1

troponin C1, slow skeletal and cardiac type, the group of Troponin complex subunits|EF-hand domain containing

Basic information

Region (hg38): 3:52451100-52454041

Previous symbols: [ "TNNC" ]

Links

ENSG00000114854NCBI:7134OMIM:191040HGNC:11943Uniprot:P63316AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • hypertrophic cardiomyopathy 13 (Moderate), mode of inheritance: AD
  • dilated cardiomyopathy 1Z (Moderate), mode of inheritance: AD
  • familial isolated dilated cardiomyopathy (Supportive), mode of inheritance: AD
  • dilated cardiomyopathy 1Z (Definitive), mode of inheritance: AD
  • dilated cardiomyopathy 1Z (Strong), mode of inheritance: AD
  • hypertrophic cardiomyopathy 13 (Strong), mode of inheritance: AD
  • hypertrophic cardiomyopathy (Definitive), mode of inheritance: AD
  • dilated cardiomyopathy (Definitive), mode of inheritance: AD
  • arrhythmogenic right ventricular cardiomyopathy (No Known Disease Relationship), mode of inheritance: AD
  • hypertrophic cardiomyopathy 13 (Definitive), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Cardiomyopathy, familial hypertrophic 13; Cardiomyopathy, dilated, 1ZADCardiovascularPreventive measures, surveillance (eg, including echocardiography and electrocardiography), and medical management may be helpful to help decrease morbidity; Cardiac transplantation has been reportedCardiovascular11385718; 15542288; 18572189

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the TNNC1 gene.

  • Dilated_cardiomyopathy_1Z (289 variants)
  • Hypertrophic_cardiomyopathy_13 (282 variants)
  • Cardiovascular_phenotype (108 variants)
  • not_provided (70 variants)
  • not_specified (50 variants)
  • Cardiomyopathy (25 variants)
  • TNNC1-related_disorder (9 variants)
  • Primary_dilated_cardiomyopathy (3 variants)
  • Hypertrophic_cardiomyopathy (3 variants)
  • Dilated_cardiomyopathy_1S (2 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the TNNC1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000003280.3. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
2
clinvar
75
clinvar
1
clinvar
78
missense
4
clinvar
11
clinvar
154
clinvar
169
nonsense
1
clinvar
1
start loss
0
frameshift
12
clinvar
12
splice donor/acceptor (+/-2bp)
1
clinvar
5
clinvar
6
Total 5 11 174 75 1

Highest pathogenic variant AF is 0.000019206725

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
TNNC1protein_codingprotein_codingENST00000232975 62969
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.6780.318125709081257170.0000318
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.774897.00.4950.000006391106
Missense in Polyphen2049.0770.40753550
Synonymous-0.7364539.11.150.00000332263
Loss of Function2.2917.990.1253.53e-7104

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001450.000145
Ashkenazi Jewish0.00009930.0000992
East Asian0.00005440.0000544
Finnish0.000.00
European (Non-Finnish)0.00001120.00000879
Middle Eastern0.00005440.0000544
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Troponin is the central regulatory protein of striated muscle contraction. Tn consists of three components: Tn-I which is the inhibitor of actomyosin ATPase, Tn-T which contains the binding site for tropomyosin and Tn-C. The binding of calcium to Tn-C abolishes the inhibitory action of Tn on actin filaments.;
Disease
DISEASE: Cardiomyopathy, dilated 1Z (CMD1Z) [MIM:611879]: A disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. Patients are at risk of premature death. {ECO:0000269|PubMed:15542288}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cardiomyopathy, familial hypertrophic 13 (CMH13) [MIM:613243]: A hereditary heart disorder characterized by ventricular hypertrophy, which is usually asymmetric and often involves the interventricular septum. The symptoms include dyspnea, syncope, collapse, palpitations, and chest pain. They can be readily provoked by exercise. The disorder has inter- and intrafamilial variability ranging from benign to malignant forms with high risk of cardiac failure and sudden cardiac death. {ECO:0000269|PubMed:11385718, ECO:0000269|PubMed:16302972, ECO:0000269|PubMed:18572189, ECO:0000269|PubMed:19439414}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Cardiac muscle contraction - Homo sapiens (human);Dilated cardiomyopathy (DCM) - Homo sapiens (human);Hypertrophic cardiomyopathy (HCM) - Homo sapiens (human);Adrenergic signaling in cardiomyocytes - Homo sapiens (human);Calcium signaling pathway - Homo sapiens (human);Disopyramide Action Pathway;Procainamide (Antiarrhythmic) Action Pathway;Phenytoin (Antiarrhythmic) Action Pathway;Fosphenytoin (Antiarrhythmic) Action Pathway;Bopindolol Action Pathway;Timolol Action Pathway;Carteolol Action Pathway;Bevantolol Action Pathway;Practolol Action Pathway;Dobutamine Action Pathway;Isoprenaline Action Pathway;Arbutamine Action Pathway;Amiodarone Action Pathway;Levobunolol Action Pathway;Metipranolol Action Pathway;Mexiletine Action Pathway;Lidocaine (Antiarrhythmic) Action Pathway;Quinidine Action Pathway;Sotalol Action Pathway;Epinephrine Action Pathway;Betaxolol Action Pathway;Atenolol Action Pathway;Alprenolol Action Pathway;Acebutolol Action Pathway;Muscle/Heart Contraction;Diltiazem Action Pathway;Propranolol Action Pathway;Pindolol Action Pathway;Penbutolol Action Pathway;Oxprenolol Action Pathway;Metoprolol Action Pathway;Esmolol Action Pathway;Bisoprolol Action Pathway;Bupranolol Action Pathway;Nebivolol Action Pathway;Amlodipine Action Pathway;Verapamil Action Pathway;Nitrendipine Action Pathway;Nisoldipine Action Pathway;Nimodipine Action Pathway;Ibutilide Action Pathway;Tocainide Action Pathway;Flecainide Action Pathway;Isradipine Action Pathway;Nifedipine Action Pathway;Felodipine Action Pathway;Nadolol Action Pathway;Carvedilol Action Pathway;Labetalol Action Pathway;MFAP5-mediated ovarian cancer cell motility and invasiveness;Striated Muscle Contraction;Striated Muscle Contraction;Muscle contraction (Consensus)

Recessive Scores

pRec
0.236

Intolerance Scores

loftool
0.220
rvis_EVS
-0.19
rvis_percentile_EVS
39.68

Haploinsufficiency Scores

pHI
0.0970
hipred
Y
hipred_score
0.555
ghis
0.615

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.801

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumLowMedium
Primary ImmunodeficiencyMediumLowMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Tnnc1
Phenotype

Zebrafish Information Network

Gene name
tnnc1a
Affected structure
cardiac muscle cell
Phenotype tag
abnormal
Phenotype quality
disorganized

Gene ontology

Biological process
diaphragm contraction;skeletal muscle contraction;regulation of muscle contraction;response to metal ion;transition between fast and slow fiber;muscle filament sliding;regulation of muscle filament sliding speed;regulation of ATPase activity;ventricular cardiac muscle tissue morphogenesis;cardiac muscle contraction
Cellular component
cytosol;troponin complex;cardiac Troponin complex
Molecular function
calcium ion binding;protein binding;troponin I binding;troponin T binding;protein homodimerization activity;calcium-dependent protein binding;actin filament binding